← Back to Search

Other

Dry Needling for Knee Pain

N/A
Recruiting
Led By Matthew S Briggs, DPT, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-40 years-of-age
Presence of anterior knee pain around the patella during ascending/descending stairs, squatting, and/or running for at least 3 months.
Must not have
Received previous dry needling treatments
History of pain less than 3 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post testing (week 3)

Summary

This trial is testing dry needling for knee pain relief in patients with patellofemoral pain syndrome. The treatment involves inserting small needles into muscles to help them relax and reduce pain. The study aims to see if this method improves pain, muscle strength, and leg function.

Who is the study for?
This trial is for individuals aged 18-40 with knee pain around the patella when doing activities like stairs, squatting, or running for at least 3 months. They must be referred for physical therapy and not currently receiving other treatments for knee pain. People can't join if they have bilateral knee syndrome, recent surgery or PT treatment, pregnancy, neurological conditions affecting movement, needle phobias, bleeding disorders, cancer diagnosis or systemic illnesses.
What is being tested?
The study examines dry needling's effectiveness in managing knee pain and improving muscle strength and leg function. Participants will receive either actual dry needling or a sham (fake) procedure alongside their regular physical therapy to compare outcomes.
What are the potential side effects?
Dry needling may cause some discomfort at the needle site, minor bleeding or bruising. Rarely it might lead to fatigue or dizziness immediately after treatment. Serious side effects are uncommon but could include infection at the puncture site.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 40 years old.
Select...
I have had knee pain near my kneecap when moving or squatting for over 3 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had dry needling treatments before.
Select...
I have been experiencing pain for less than 3 months.
Select...
I do not have bleeding disorders, needle phobia, active cancer, or any illness like fever or infection.
Select...
I have had surgery to fix my kneecap alignment.
Select...
I have pain in the front of both knees.
Select...
I have a condition that affects my ability to move.
Select...
I am unable to give my consent.
Select...
My kneecap frequently dislocates or feels unstable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post testing (week 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post testing (week 3) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline Anterior Knee Pain Scale (AKPS) score to 3 weeks
Change from Baseline Numeric Pain Rating Scale (NPRS) score to 3 weeks
Secondary study objectives
Change from Baseline Isometric knee and hip peak torque values to 3 weeks
Lysergic Acid Diethylamide
Change from Baseline Lower Extremity Functional Scale (LEFS) score to 3 weeks
+1 more

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Quad Dry NeedlingExperimental Treatment1 Intervention
Receives dry needling to their quadriceps muscles in addition to standard physical therapy treatment.
Group II: Glute Dry NeedlingExperimental Treatment1 Intervention
Receives dry needling to their gluteal muscles in addition to standard physical therapy treatment.
Group III: ControlActive Control1 Intervention
Receives only standard physical therapy treatment.
Group IV: Glute Sham Dry NeedlingPlacebo Group1 Intervention
Receives sham dry needling to their gluteal muscles in addition to standard physical therapy treatment.
Group V: Quad Sham Dry NeedlingPlacebo Group1 Intervention
Receives sham dry needling to their quadriceps muscles in addition to standard physical therapy treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dry Needling
2020
Completed Phase 2
~1090

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Patellofemoral Pain Syndrome (PFPS) often focus on muscle relaxation and pain relief, similar to the mechanisms of dry needling. Dry needling involves inserting small needles into muscle tissue to release tension and reduce pain by promoting muscle relaxation and improving blood flow. This is crucial for PFPS patients as it helps alleviate the pain and discomfort associated with muscle tightness and imbalances around the knee joint. Other treatments, such as physical therapy exercises, aim to strengthen and stretch the muscles around the knee, improving alignment and reducing stress on the patellofemoral joint. These approaches collectively help in managing pain and enhancing knee function, which is essential for the daily activities and overall quality of life of PFPS patients.
Patellar taping for patellofemoral pain syndrome in adults.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
655,037 Total Patients Enrolled
1 Trials studying Patellofemoral Pain Syndrome
60 Patients Enrolled for Patellofemoral Pain Syndrome
Matthew S Briggs, DPT, PhDPrincipal InvestigatorThe Ohio State University Wexner Medical Center
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Patellofemoral Pain Syndrome
60 Patients Enrolled for Patellofemoral Pain Syndrome

Media Library

Dry Needling (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02890485 — N/A
Patellofemoral Pain Syndrome Research Study Groups: Control, Glute Sham Dry Needling, Quad Sham Dry Needling, Quad Dry Needling, Glute Dry Needling
Patellofemoral Pain Syndrome Clinical Trial 2023: Dry Needling Highlights & Side Effects. Trial Name: NCT02890485 — N/A
Dry Needling (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02890485 — N/A
~23 spots leftby Dec 2026